ArticlePLoS medicine2016

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.

Amélie Le Bihan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.